In the world of cutting-edge biological research, precision isn't just a goal
Therefore, intrinsic cardiac load and capacity do not improve in patients with heart failure with reduced ejection fraction, and patients HFpEF benefit only from the treatment of abnormal metabolism and inflammation.475,480,481 The encouraging results obtained with semaglutide in patients with heart failure and a preserved ejection fraction may provide a new option for this patient population, in which additional therapy, as well as another upstream therapy for patients with a higher BMI who have indications for this condition, is urgently needed
Instantly download my GLP-1 hacks as a free PDF below
Fast And easy
Ask them for the trial data
Alison Cave, Chief Safety Officer at the MHRA, UK, emphasised that this research will enable safer prescribing by identifying individuals most at risk of serious side effects